Scholarly Index
Rahul Aggarwal
University of California, San Francisco; 10,031 total citations; 440 total publications; best world rank #24
University of California, San Francisco
10,031Total citations
440Total publications
47H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Radiopharmaceutical Chemistry and Applications | Lifetime | 350 | US 151 | 97.94 |
| Prostate Cancer Treatment and Research | Lifetime | 554 | US 300 | 98.45 |
| PARP inhibition in cancer therapy | Lifetime | 758 | US 319 | 92.38 |
| Prostate Cancer Treatment and Research | 2021-2025 | 31 | US 14 | 99.63 |
| Radiopharmaceutical Chemistry and Applications | 2021-2025 | 24 | US 10 | 99.24 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 530 | US 201 | 97.93 |
| Peptidase Inhibition and Analysis | 2021-2025 | 157 | US 44 | 96.40 |
| Lung Cancer Research Studies | 2021-2025 | 192 | US 74 | 97.51 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 191 | US 49 | 94.30 |
| Ubiquitin and proteasome pathways | 2021-2025 | 214 | US 51 | 92.19 |
| Prostate Cancer Diagnosis and Treatment | 2021-2025 | 381 | US 111 | 96.01 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 835 | US 265 | 89.86 |
| PARP inhibition in cancer therapy | 2021-2025 | 380 | US 149 | 89.23 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 700 | US 177 | 88.87 |